Aruba Health Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Health Monitor.

Press releases published on November 12, 2026

5 hours ago

AI Disruption in Virtual Mirror Technology Signals Inflection Point for Retail Investment

Indeterminate GlobeNewswire

6 hours ago

HerScan CEO CiCi McMullen Featured in Forbes for Leadership in Expanding Breast Health Screenings

Indeterminate GlobeNewswire

6 hours ago

NeOnc Insider Buying Expands Ahead of FDA Discussions and Two Key Brain Cancer Data Presentations

Indeterminate GlobeNewswire

6 hours ago

Olema Oncology Announces Corporate Name Change

Indeterminate GlobeNewswire

6 hours ago

LiveWorld Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

6 hours ago

Olympia Pharmaceuticals to Compound Select Peptides Under HHS Interim Enforcement Policy

Indeterminate GlobeNewswire

7 hours ago

Medicana Expert Highlights: New Study Finds Better One-Year Outcomes After Robot-Assisted Knee Replacement

Indeterminate GlobeNewswire

7 hours ago

Alps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction Testing

Indeterminate GlobeNewswire

7 hours ago

HOLLYWOOD HAS THE FANS. WHO BUILDS THE BUSINESS?

Indeterminate GlobeNewswire

7 hours ago

Moleculin Secures Australian Patent for Annamycin Formulation Technology

Indeterminate GlobeNewswire

7 hours ago

PRM Establishes West Palm Beach as National Epicenter for Pelvic Health Innovation and Physician Training

Indeterminate GlobeNewswire

7 hours ago

Autonomix Highlights Renal Denervation Strategy and Vision for Illuminating the Nervous System at TCT 2026

Indeterminate GlobeNewswire

7 hours ago

CytoDyn Announces $5 Million Private Investment to Advance Leronlimab in Colorectal Cancer and Other Solid Tumors

Indeterminate GlobeNewswire

7 hours ago

Sol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

7 hours ago

Alpha Tau to Host Investor Call to Review New Data from the Alpha DaRT® Recurrent Glioblastoma REGAIN Trial

Indeterminate GlobeNewswire

7 hours ago

Axiom Biosciences Announces Regulation Crowdfunding Offering With Wefunder Community Round

Indeterminate GlobeNewswire

7 hours ago

CollPlant to Begin Trading on Nasdaq Under New Ticker Symbol “OPHI”

Indeterminate GlobeNewswire

7 hours ago

Evaxion announce 2027 financial calendar

Indeterminate GlobeNewswire

7 hours ago

Artelo Biosciences Provides Business Update and Reports 2026 Third Quarter Financial Results

Indeterminate GlobeNewswire

7 hours ago

Hyro Achieves Oracle Validated: Oracle Health Endpoint Validation Expertise for Delivering Proven Agentic AI EHR Integration

Indeterminate GlobeNewswire